Room: Ibiza
Tuesday 31 May
10:00-11:30
Parallel 5b: Cell and gene therapy of Neural diseases
Chair: Juan José Toledo-Aral, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla
10:00 Benedikt Berninger, Institute of Psychiatry, Psychology & Neuroscience Centre for Developmental Neurobiology & MRC Centre for Neurodevelopmental Disorders, King's College London ⓘ
INV30 Advancing in vivo glia-to-neuron reprogramming as an innovative approach for brain repair: promises, disappointments, and breakthroughs
10:30 Juan Ruiz, Forge Therapeutics
INV31 The RESKUE Trial - a Phase 1/2 Clinical Trial for Patients with Krabbe Disease
11:00 Sergi Verdés, Institut de Neurociències (INc), Universitat Autònoma de Barcelona (UAB)
OR11 Gene therapy for ALS by specifically overexpressing a pleiotropic chronokine, secreted α-Klotho (s-KL), in skeletal muscles
11:15 Nieves Iria Domínguez-García, Instituto de Biomedicina de Sevilla (IBiS)
OR12 Pathophysiological alterations of regulatory T cells in Parkinson's disease and generation of aSyn-CAR-Tregs as a novel therapeutic approach